Get the Stockscreener App
0.8688
4.26%
-0.0387
After Hours:
.85
-0.0188
-2.16%
Ispecimen Inc stock is traded at $0.8688, with a volume of 751.56K.
It is down -4.26% in the last 24 hours and down -33.68% over the past month.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
See More
Previous Close:
$0.9075
Open:
$0.909
24h Volume:
751.56K
Relative Volume:
0.12
Market Cap:
$4.81M
Revenue:
$10.39M
Net Income/Loss:
$-9.52M
P/E Ratio:
-0.0454
EPS:
-19.12
Net Cash Flow:
$-6.02M
1W Performance:
-23.79%
1M Performance:
-33.68%
6M Performance:
-31.59%
1Y Performance:
-79.89%
1-Day Range:
$0.82
$0.94
1-Week Range:
$0.82
$1.1599
52-Week Range:
$0.64
$8.30
Ispecimen Inc Stock (ISPC) Company Profile
Name
Ispecimen Inc
Sector
Industry
Phone
781-301-6700
Address
8 CABOT ROAD, WOBURN
Compare ISPC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ISPC
Ispecimen Inc
|
0.8688 | 7.45M | 10.39M | -9.52M | -6.02M | -19.12 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Ispecimen Inc Stock (ISPC) Latest News
Is iSpecimen Inc. stock poised for growthTrend Reversal & Risk Managed Trade Strategies - newser.com
How to integrate iSpecimen Inc. into portfolio analysis toolsQuarterly Market Review & Smart Allocation Stock Tips - newser.com
iSpecimen plans $200M Solana-based digital asset treasury - MSN
Will iSpecimen Inc. stock go up soonWeekly Stock Analysis & Weekly Chart Analysis and Trade Guides - newser.com
Can momentum traders help lift iSpecimen Inc.July 2025 Breakouts & Real-Time Volume Analysis - newser.com
Using data tools to time your iSpecimen Inc. exit2025 Geopolitical Influence & High Accuracy Investment Signals - newser.com
Using data models to predict iSpecimen Inc. stock movementWeekly Gains Report & Low Risk Entry Point Tips - newser.com
Detecting support and resistance levels for iSpecimen Inc.Portfolio Risk Summary & Growth Focused Stock Reports - newser.com
iSpecimen Inc. stock volume spike explainedWeekly Volume Report & AI Driven Price Predictions - newser.com
How to recover losses in iSpecimen Inc. stockJuly 2025 Update & Community Supported Trade Ideas - newser.com
Nutex Health (NASDAQ:NUTX) versus iSpecimen (NASDAQ:ISPC) Financial Analysis - Defense World
Institutional scanner results for iSpecimen Inc.2025 Earnings Impact & Technical Analysis for Trade Confirmation - newser.com
Heatmap analysis for iSpecimen Inc. and competitors2025 Retail Activity & Community Verified Swing Trade Signals - newser.com
Is now a turning point for iSpecimen Inc.Quarterly Earnings Report & Long-Term Capital Growth Strategies - newser.com
Certain Pre-funded Warrants of iSpecimen Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2025. - MarketScreener
Certain Warrants of iSpecimen Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2025. - MarketScreener
Certain Options of iSpecimen Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2025. - MarketScreener
Can you recover from losses in iSpecimen Inc.Portfolio Value Report & Free Safe Entry Trade Signal Reports - newser.com
Is iSpecimen Inc. building a consolidation baseQuarterly Portfolio Summary & Daily Oversold Stock Bounce Ideas - newser.com
Will iSpecimen Inc. rebound enough to break even2025 Historical Comparison & Risk Adjusted Buy and Sell Alerts - newser.com
iSpecimen appoints Robert Lim as CEO - MSN
Ispecimen Inc Stock (ISPC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.17%
2.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):